Your browser doesn't support javascript.
COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.
Perri, Melissa; Schmidt, Rose A; Guta, Adrian; Kaminski, Nat; Rudzinski, Katherine; Strike, Carol.
  • Perri M; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Schmidt RA; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Guta A; School of Social Work, University of Windsor, Windsor, ON, Canada.
  • Kaminski N; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Canadian Association of People Who Use Drugs, Dartmouth, NS, Canada.
  • Rudzinski K; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; School of Social Work, University of Windsor, Windsor, ON, Canada.
  • Strike C; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; MAP Center for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada. Electronic address: carol.strike@utoronto.ca.
Int J Drug Policy ; 108: 103815, 2022 10.
Article in English | MEDLINE | ID: covidwho-2061065
ABSTRACT
The COVID-19 pandemic has increased the uptake of virtual and remote service delivery in the substance use field, which was previously uncommon. This swift uptake of virtual services provides an opportunity to improve service design to meet the diverse needs of women and gender-diverse people. Such services have the potential to better meet the needs of women and gender-diverse people by allowing for increased choice, control, and autonomy, enabling empowerment, facilitating greater considerations of power relations, violence, childcare responsibilities, and fostering greater inclusion of trans and non-binary people. This commentary aims to identify how virtual and remote delivery of substance use treatment and harm reduction services can be gender-responsive. We highlight the role gender transformative services play in meeting the unique needs of women and gender-diverse people who use drugs both during and after the COVID-19 pandemic. By using the unique window of opportunity COVID-19 has created to develop and deliver gender-transformative programs, we can help address the detrimental gaps in service accessibility and effectiveness that have persistently been experienced by women and gender-diverse people who use drugs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Substance-Related Disorders / COVID-19 Limits: Female / Humans Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article Affiliation country: J.drugpo.2022.103815

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Substance-Related Disorders / COVID-19 Limits: Female / Humans Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2022 Document Type: Article Affiliation country: J.drugpo.2022.103815